The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life Sciences Supplement.
The Supplement – created by M&A professionals from across our global Life Sciences sector team – covers M&A deal activity in 2022 and supplements our 2023 global M&A Intelligence Report, which is now in its ninth edition.
The report looks at a selection of our international corporate life sciences transactions to identify trends and developments, which can provide insightful intelligence for those operating in the sector and considering M&A activity, both domestically or internationally.
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-06-07-08-32-37-760-6662c5a5e17f2f97387a4d96.png)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-07-25-10-18-27-122-66a22673360ba83a1870b4e7.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-07-22-08-59-02-553-669e1f560e665f7cf84d24e4.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-07-09-15-46-56-542-A24006_Life_Sciences_June_2024_Brochure_ENv2_thumbnail_1.png)
